+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Endoscopic markers of villous atrophy are not useful for the detection of celiac disease in patients with dyspeptic symptoms

Endoscopic markers of villous atrophy are not useful for the detection of celiac disease in patients with dyspeptic symptoms

Endoscopy 38(7): 696-701

Celiac disease can manifest with nonspecific symptoms, including functional gastrointestinal disorders such as dyspepsia. The aim of our study was to assess the usefulness of duodenal endoscopic markers of villous atrophy for the selection of dyspeptic patients for histological assessment. Esophagogastroduodenoscopy was performed in dyspeptic patients, in patients considered to be at risk of having celiac disease, and in healthy controls. At least three duodenal biopsies were performed for histological assessment of villous atrophy in all patients and controls. We looked for the following four duodenal endoscopic markers of celiac disease: reduction in the number of folds, scalloping of folds, mosaic-pattern mucosa, and nodular mucosa. A total of 175 people were enrolled (75 patients with dyspepsia; 75 patients who were "at risk" of having celiac disease; and 25 healthy volunteers, or "controls"). Of the dyspeptic patients, four had endoscopic markers of celiac disease with no histologically confirmed villous atrophy, while one patient without endoscopic markers was found to have Marsh type I villous atrophy. Of the patients at risk of having celiac disease, 16 had at least one endoscopic marker and 10/16 were found to have histological villous atrophy. In this group, the sensitivity and specificity of the endoscopic markers were 100 % and 90.8 % respectively. "At-risk" patients with two or more endoscopic markers all had histologically confirmed villous atrophy. Neither endoscopic markers nor villous atrophy were found in any of the control patients. Additional endoscopic markers are valuable for diagnosis in patients with clinical symptoms suggestive of celiac disease. In contrast, endoscopic markers of villous atrophy are not useful for selecting a subgroup of dyspeptic patients for screening for celiac disease by duodenal histological assessment. These patients should be screened using other protocols.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 048952633

Download citation: RISBibTeXText

PMID: 16761210

DOI: 10.1055/s-2006-925373

Related references

Detection of villous atrophy using endoscopic images for the diagnosis of celiac disease. Digestive Diseases and Sciences 58(5): 1167-1169, 2013

Disappointing sensitivity of Endoscopic markers for villous atrophy in a high-risk population: Implications for celiac disease diagnosis during routine endoscopy. American Journal of Gastroenterology 96(7): 2126-2128, 2001

No Difference Between Latiglutenase and Placebo in Reducing Villous Atrophy or Improving Symptoms in Patients With Symptomatic Celiac Disease. Gastroenterology 152(4): 787-798.E2, 2016

Quantitative assessment of endoscopic images for degree of villous atrophy in celiac disease. Digestive Diseases and Sciences 56(3): 805-811, 2011

Nutritional status of newly diagnosed celiac disease patients before and after the institution of a celiac disease diet--association with the grade of mucosal villous atrophy. American Journal of Clinical Nutrition 67(3): 482-487, 1998

Screening for celiac disease in Down's syndrome patients revealed cases of subtotal villous atrophy without typical for celiac disease HLA-DQ and tissue transglutaminase antibodies. World Journal of Gastroenterology 12(9): 1430-1434, 2006

Patients of celiac disease with mild villous atrophy are clinically similar to those with moderate to severe atrophy. Indian Journal of Gastroenterology 32(6): 413-414, 2014

M2054 Correlation of Histological Villous Atrophy with Tissue Transglutaminase Antibody Level in Patients with Diagnosis of Celiac Disease: Retrospective Analysis of a Cohort of 187 Celiac Patients. Gastroenterology 136(5): A-475-A-476, 2009

Sa1315 Vitamin D Deficiency Does Not Correlate With Villous Atrophy in Patients With Celiac Disease. Gastroenterology 142(5): S-271, 2012

Recommendations to quantify villous atrophy in video capsule endoscopy images of celiac disease patients. World Journal of Gastrointestinal Endoscopy 8(18): 653-662, 2016

Sa1294 Lymphocytic Gastritis in Patients With Celiac Disease; Increasing Prevalence According to Age and Severity of Villous Atrophy. Gastroenterology 148(4): S-284, 2015

Classification of villous atrophy with enhanced magnification endoscopy in patients with celiac disease and tropical sprue. Gastrointestinal Endoscopy 66(2): 377-382, 2007

Detection of autoantibodies against enterocyte actin filaments as serological predictive test for intestinal villous atrophy in celiac disease results of a polycentric study. Digestive Disease Week Abstracts & Itinerary Planner : Abstract No W1384, 2003

Extraction and processing of videocapsule data to detect and measure the presence of villous atrophy in celiac disease patients. Computers in Biology and Medicine 78: 97-106, 2016

Optical coherence tomography in pediatric patients: a feasible technique for diagnosing celiac disease in children with villous atrophy. Digestive and Liver Disease 41(9): 639-643, 2009